Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 15/20 | 0.47 |
| ▸ | CNR2 | P34972 | 15/20 | 0.47 |
| ▸ | BACE1 | P56817 | 2/20 | 0.46 |
| ▸ | ESR1 | P03372 | 3/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.44 |
| ▸ | AR | P10275 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19902034 | 0.91 | CNR1 (0.54) | CNR1CNR2ESR1ESR2 | |
| SCHEMBL5652317 | 0.90 | CNR1 (0.60) | CNR1CNR2 | |
| SCHEMBL9817011 | 0.88 | BACE1 (0.46) | CNR1CNR2BACE1ESR1ESR2 | |
| SCHEMBL9817005 | 0.87 | ESR1 (0.59) | BACE1ESR1ESR2AR | |
| SCHEMBL9817091 | 0.84 | ESR1 (0.51) | BACE1ESR1ESR2AR | |
| SCHEMBL2867989 | 0.83 | BACE1 (0.44) | CNR1CNR2BACE1ESR1ESR2 | |
| SCHEMBL29538101 | 0.83 | CYP3A4 (0.49) | CNR1CNR2BACE1ESR1ESR2 | |
| SCHEMBL647965 | 0.83 | CYP3A4 (0.49) | CNR1CNR2BACE1ESR1ESR2 | |
| SCHEMBL9817095 | 0.82 | ESR1 (0.58) | BACE1ESR1ESR2AR | |
| SCHEMBL9816981 | 0.82 | ESR1 (0.46) | CNR1CNR2BACE1ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10011676-B2 | Compound containing phenolic hydroxyl group, phenolic resin, curable composition, cured product thereof, semiconductor sealing material, and printed circuit board | DIC CORPORATION (JP) | 2018-07-03 | — | — | US | disclosed |
| US-20160137770-A1 | COMPOUND CONTAINING PHENOLIC HYDROXYL GROUP, PHENOLIC RESIN, CURABLE COMPOSITION, CURED PRODUCT THEREOF, SEMICONDUCTOR SEALING MATERIAL, AND PRINTED CIRCUIT BOARD | DIC CORPORATION (JP) | 2016-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160137770-A1 | COMPOUND CONTAINING PHENOLIC HYDROXYL GROUP, PHENOLIC RESIN, CURABLE COMPOSITION, CURED PRODUCT THEREOF, SEMICONDUCTOR SEALING MATERIAL, AND PRINTED CIRCUIT BOARD | ASH2L, SEM1, KDM1A | CNR1 3279/4885CNR2 4169/4885BACE1 2438/4885 |
| US-10011676-B2 | Compound containing phenolic hydroxyl group, phenolic resin, curable composition, cured product thereof, semiconductor sealing material, and printed circuit board | ASH2L, SEM1, KDM1A | CNR1 3279/4885CNR2 4169/4885BACE1 2438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.